A Biden campaign ad out this month attacks President Donald Trump for pushing to slash Medicare benefits. A campaign spokesperson said the claim comes from the administration’s support for a legal challenge to the Affordable Care Act that seeks to nullify the entire law.
Trump claims the U.S. is “rounding the corner” on COVID, while Biden predicts a “dark winter.” On another front, Trump warns Biden’s health care plan will lead to socialized medicine; Biden promises private insurance isn’t going anywhere.
Glimmers of hope are beginning to appear in the fight against the coronavirus, such as a decreasing death rate. But there’s not-so-good news, too, including a push for “herd immunity,” which could result in millions more deaths. Meanwhile, the Trump administration doubles down on work requirements for Medicaid. Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
The number is taken from a hypothetical modeling scenario that doesn’t offer a realistic comparison.
The World Health Organization has been consistent throughout the pandemic in communicating that lockdowns should be employed only when COVID-19 cases are high — to give governments and health systems time to redouble efforts. Forced closures should not be the primary strategy to combat coronavirus transmission.
The vice president went on to point out the underlying philosophical differences between President Donald Trump and Joe Biden regarding their approaches to COVID-19.
In less than six years, Sen. Joni Ernst has gone from being a rising star in the Republican Party to running neck and neck against a political newcomer. A poll last month showed more than 1 in 3 Iowa voters think Ernst’s relationship to President Donald Trump is “too close,” and her comments about the coronavirus death toll sparked a backlash.
President Donald Trump has been heralding drugmakers as “great companies.” Yet in the final stretch of the presidential campaign, Trump is not feeling the love in pharma contributions. Former Vice President Joe Biden is, even though his proposed policies could dent the industry’s profitability.
President Donald Trump is one of at least two dozen people tied to the White House who have tested positive for COVID-19. Negotiations on the next round of COVID relief are off again — maybe. And the FDA and CDC continue to fight for scientific credibility. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Erin Mershon of Stat News join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews Amy Howe of SCOTUSblog about what the Supreme Court might do with the latest case challenging the constitutionality of the Affordable Care Act.
During this, the first and only vice presidential debate of the 2020 election season, the two candidates clashed over the coronavirus and other health care issues, as well as a range of other topics.
